Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Penzel

Showing results (91-100 of 132) with videos related to

Pageof 14
Sort By:
Genes, Chromosomes & Cancer|October 30, 2016
Targeted next-generation sequencing enables reliable detection of HER2 (ERBB2) status in breast cancer and provides ancillary information of clinical relevanceNicole Pfarr, Roland Penzel, Volker Endris, et al.
Genes, Chromosomes & Cancer|September 20, 2018
Next generation sequencing of the cellular and liquid fraction of pancreatic cyst fluid supports discrimination of IPMN from pseudocysts and reveals cases with multiple mutated driver clones: First findings from the prospective ZYSTEUS biomarker studyAnna-Lena Volckmar, Volker Endris, Matthias M Gaida, et al.
Cancer Research|March 5, 2009
Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancerStephan Singer, Mona Malz, Esther Herpel, et al.
International Journal of Cancer|September 22, 2018
Size matters: Dissecting key parameters for panel-based tumor mutational burden analysisIvo Buchhalter, Eugen Rempel, Volker Endris, et al.
Genes, Chromosomes & Cancer|July 21, 2016
Tubular, lactating, and ductal adenomas are devoid of MED12 Exon2 mutations, and ductal adenomas show recurrent mutations in GNAS and the PI3K-AKT pathwayAnna-Lena Volckmar, Jonas Leichsenring, Christa Flechtenmacher, et al.
International Journal of Cancer|December 4, 2010
Phosphatidylinositol-3'-kinase/AKT signaling is essential in synovial sarcomaNicolaus Friedrichs, Marcel Trautmann, Elmar Endl, et al.
Hepatology (Baltimore, Md.)|October 28, 2010
Down-regulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanismsBenjamin Goeppert, Peter Schmezer, Céline Dutruel, et al.
Plos One|September 27, 2017
CT characteristics in pulmonary adenocarcinoma with epidermal growth factor receptor mutationJing Zhao, Julien Dinkel, Arne Warth, et al.
Lung Cancer (Amsterdam, Netherlands)|April 10, 2012
The gefitinib long-term responder (LTR)--a cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP)Sandra Gottschling, Esther Herpel, Wilfried E E Eberhardt, et al.
The European Respiratory Journal|March 21, 2015
Erlotinib and bevacizumab versus cisplatin, gemcitabine and bevacizumab in unselected nonsquamous nonsmall cell lung cancerMichael Thomas, Jürgen Fischer, Stefan Andreas, et al.
Pageof 14

Showing results (91-100 of 132) with videos related to

Sort By:
Pageof 14
Genes, Chromosomes & Cancer|October 30, 2016
Targeted next-generation sequencing enables reliable detection of HER2 (ERBB2) status in breast cancer and provides ancillary information of clinical relevanceNicole Pfarr, Roland Penzel, Volker Endris, et al.
Genes, Chromosomes & Cancer|September 20, 2018
Next generation sequencing of the cellular and liquid fraction of pancreatic cyst fluid supports discrimination of IPMN from pseudocysts and reveals cases with multiple mutated driver clones: First findings from the prospective ZYSTEUS biomarker studyAnna-Lena Volckmar, Volker Endris, Matthias M Gaida, et al.
Cancer Research|March 5, 2009
Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancerStephan Singer, Mona Malz, Esther Herpel, et al.
International Journal of Cancer|September 22, 2018
Size matters: Dissecting key parameters for panel-based tumor mutational burden analysisIvo Buchhalter, Eugen Rempel, Volker Endris, et al.
Genes, Chromosomes & Cancer|July 21, 2016
Tubular, lactating, and ductal adenomas are devoid of MED12 Exon2 mutations, and ductal adenomas show recurrent mutations in GNAS and the PI3K-AKT pathwayAnna-Lena Volckmar, Jonas Leichsenring, Christa Flechtenmacher, et al.
International Journal of Cancer|December 4, 2010
Phosphatidylinositol-3'-kinase/AKT signaling is essential in synovial sarcomaNicolaus Friedrichs, Marcel Trautmann, Elmar Endl, et al.
Hepatology (Baltimore, Md.)|October 28, 2010
Down-regulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanismsBenjamin Goeppert, Peter Schmezer, Céline Dutruel, et al.
Plos One|September 27, 2017
CT characteristics in pulmonary adenocarcinoma with epidermal growth factor receptor mutationJing Zhao, Julien Dinkel, Arne Warth, et al.
Lung Cancer (Amsterdam, Netherlands)|April 10, 2012
The gefitinib long-term responder (LTR)--a cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP)Sandra Gottschling, Esther Herpel, Wilfried E E Eberhardt, et al.
The European Respiratory Journal|March 21, 2015
Erlotinib and bevacizumab versus cisplatin, gemcitabine and bevacizumab in unselected nonsquamous nonsmall cell lung cancerMichael Thomas, Jürgen Fischer, Stefan Andreas, et al.
Pageof 14